Bioinformatics company M2GEN teams up with Microsoft on oncology projects

December 16 2021

M2GEN, a Florida-based bioinformatics company announced a partnership with Microsoft to support its clinic-genomics database with Azure.

M2GEN has collected a database of 300,000 cancer patients in coordination with the Oncology Research Information Exchange Network. It plans to scale this data with Synapse Analytics and Healthcare APIs. The new platform will rely on Purview and Data Lake Storage Gen2.

"Microsoft's commitment to life science and its superior technologies make them a partner of choice for M2GEN. Together, our two companies will accelerate the impact of data and analytics on personalized cancer care for patients,” stated Jim Gabriele, President and Chief Executive Officer of M2GEN.

“At Microsoft, we have long recognized the tremendous opportunity for advanced computational data to improve global health outcomes for all patients in need. M2GEN has taken the first step, assembling an extensive cancer dataset that has already fueled important breakthroughs in precision oncology. We look forward to working with M2GEN to produce meaningful solutions for oncology researchers,” said Tom McGuinness, Corporate Vice President for Global Healthcare & Life Sciences at Microsoft, in a statement.

About MSCN Reporter

More about MSCN Reporter